BTIG Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $40
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
BTIG analyst Thomas Shrader initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $40.
BTIG analyst Thomas Shrader initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $40.